109 related articles for article (PubMed ID: 25746354)
1. Boldine, a natural aporphine alkaloid, inhibits telomerase at non-toxic concentrations.
Kazemi Noureini S; Tanavar F
Chem Biol Interact; 2015 Apr; 231():27-34. PubMed ID: 25746354
[TBL] [Abstract][Full Text] [Related]
2. Telomerase Inhibition by a New Synthetic Derivative of the Aporphine Alkaloid Boldine.
Kazemi Noureini S; Kheirabadi M; Masoumi F; Khosrogerdi F; Zarei Y; Suárez-Rozas C; Salas-Norambuena J; Kennedy Cassels B
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29671783
[TBL] [Abstract][Full Text] [Related]
3. Dose-dependent cytotoxic effects of boldine in HepG-2 cells-telomerase inhibition and apoptosis induction.
Noureini SK; Wink M
Molecules; 2015 Feb; 20(3):3730-43. PubMed ID: 25719742
[TBL] [Abstract][Full Text] [Related]
4. Gefitinib induces apoptosis and decreases telomerase activity in MDA-MB-231 human breast cancer cells.
Moon DO; Kim MO; Heo MS; Lee JD; Choi YH; Kim GY
Arch Pharm Res; 2009 Oct; 32(10):1351-60. PubMed ID: 19898796
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of cytotoxic and chemotherapeutic properties of boldine in breast cancer using in vitro and in vivo models.
Paydar M; Kamalidehghan B; Wong YL; Wong WF; Looi CY; Mustafa MR
Drug Des Devel Ther; 2014; 8():719-33. PubMed ID: 24944509
[TBL] [Abstract][Full Text] [Related]
6. Boldine Inhibits Mouse Mammary Carcinoma In Vivo and Human MCF-7 Breast Cancer Cells In Vitro.
Tomšík P; Mičuda S; Muthná D; Čermáková E; Havelek R; Rudolf E; Hroch M; Kadová Z; Řezáčová M; Ćmielová J; Živný P
Planta Med; 2016 Nov; 82(16):1416-1424. PubMed ID: 27611982
[TBL] [Abstract][Full Text] [Related]
7. Pterostilbene down-regulates hTERT at physiological concentrations in breast cancer cells: Potentially through the inhibition of cMyc.
Daniel M; Tollefsbol TO
J Cell Biochem; 2018 Apr; 119(4):3326-3337. PubMed ID: 29125889
[TBL] [Abstract][Full Text] [Related]
8. Telomere shortening in breast cancer cells (MCF7) under treatment with low doses of the benzylisoquinoline alkaloid chelidonine.
Kazemi Noureini S; Fatemi L; Wink M
PLoS One; 2018; 13(10):e0204901. PubMed ID: 30281650
[TBL] [Abstract][Full Text] [Related]
9. Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells.
Jagadeesh S; Kyo S; Banerjee PP
Cancer Res; 2006 Feb; 66(4):2107-15. PubMed ID: 16489011
[TBL] [Abstract][Full Text] [Related]
10. The aporphine alkaloid boldine improves endothelial function in spontaneously hypertensive rats.
Lau YS; Machha A; Achike FI; Murugan D; Mustafa MR
Exp Biol Med (Maywood); 2012 Jan; 237(1):93-8. PubMed ID: 22156043
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid inhibits telomerase activity and downregulates expression but does not affect splicing of hTERT: correlation with cell growth rate inhibition in an in vitro cervical carcinogenesis/multidrug-resistance model.
Ding Z; Green AG; Yang X; Chernenko G; Tang SC; Pater A
Exp Cell Res; 2002 Jan; 272(2):185-91. PubMed ID: 11777343
[TBL] [Abstract][Full Text] [Related]
12. Inactive C-terminal telomerase reverse transcriptase insertion splicing variants are dominant-negative inhibitors of telomerase.
Zhu S; Rousseau P; Lauzon C; Gandin V; Topisirovic I; Autexier C
Biochimie; 2014 Jun; 101():93-103. PubMed ID: 24412622
[TBL] [Abstract][Full Text] [Related]
13. Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity.
Ducrest AL; Amacker M; Mathieu YD; Cuthbert AP; Trott DA; Newbold RF; Nabholz M; Lingner J
Cancer Res; 2001 Oct; 61(20):7594-602. PubMed ID: 11606399
[TBL] [Abstract][Full Text] [Related]
14. hTERT gene expression levels and telomerase activity in drug resistant MCF-7 cells.
Sakin V; Eskiocak U; Kars MD; Iseri OD; Gunduz U
Exp Oncol; 2008 Sep; 30(3):202-5. PubMed ID: 18806742
[TBL] [Abstract][Full Text] [Related]
15. Telomere shortening and cell senescence induced by perylene derivatives in A549 human lung cancer cells.
Taka T; Huang L; Wongnoppavich A; Tam-Chang SW; Lee TR; Tuntiwechapikul W
Bioorg Med Chem; 2013 Feb; 21(4):883-90. PubMed ID: 23321015
[TBL] [Abstract][Full Text] [Related]
16. Telomerase as a Possible Candidate Targeting Therapy in Different Breast Cancer Cell Lines.
Aboelela S; Ashmawy A; Shaarawy S; El-Hefny M; Medhat A
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2243-2250. PubMed ID: 32856851
[TBL] [Abstract][Full Text] [Related]
17. Genistein induces cell growth inhibition in prostate cancer through the suppression of telomerase activity.
Ouchi H; Ishiguro H; Ikeda N; Hori M; Kubota Y; Uemura H
Int J Urol; 2005 Jan; 12(1):73-80. PubMed ID: 15661057
[TBL] [Abstract][Full Text] [Related]
18. Boldine and related aporphines: from antioxidant to antiproliferative properties.
Muthna D; Cmielova J; Tomsik P; Rezacova M
Nat Prod Commun; 2013 Dec; 8(12):1797-800. PubMed ID: 24555301
[TBL] [Abstract][Full Text] [Related]
19. EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis.
Mittal A; Pate MS; Wylie RC; Tollefsbol TO; Katiyar SK
Int J Oncol; 2004 Mar; 24(3):703-10. PubMed ID: 14767556
[TBL] [Abstract][Full Text] [Related]
20. Boldine: a potential new antiproliferative drug against glioma cell lines.
Gerhardt D; Horn AP; Gaelzer MM; Frozza RL; Delgado-Cañedo A; Pelegrini AL; Henriques AT; Lenz G; Salbego C
Invest New Drugs; 2009 Dec; 27(6):517-25. PubMed ID: 19050827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
